Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
Date:
29 Aug,2022
5 Month, Acquiring Tangshan Bohai Pharmaceutical Co., Ltd.
Previous page
2009
2004
Next page
Related Recommendations
2023/06/02
News | Inspection teams from the National Institute for Food and Drug Control, Zhejiang Provincial Institute of Drug Control, and Taizhou Municipal Institute of Drug Control visit Wanbangde for research and guidance
"Building Momentum Gradually | Postdoctoral Research Workstation Accelerates Ahead, Bolstering Pharmaceutical Group’s Scientific Innovation with Fresh Talent!"
Brand Revitalization | The 2023 China Brand Value Evaluation Report Released—Wanbangde Pharmaceutical Group Listed Again!